News &
Media
-
Neurotech’s Rett Syndrome trial results published in scientific journal
View More: Neurotech’s Rett Syndrome trial results published in scientific journal -
Long Shortz with Neurotech: Inside the groundbreaking science of NTI164
View More: Long Shortz with Neurotech: Inside the groundbreaking science of NTI164 -
WTF: Treating neurodevelopmental diseases differently – why NTI164 offers new hope
View More: WTF: Treating neurodevelopmental diseases differently – why NTI164 offers new hope -
Neurotech’s cannabinoid drug reports positive results from key study
View More: Neurotech’s cannabinoid drug reports positive results from key study -
Neurotech announces positive human PK study results for NTI164
View More: Neurotech announces positive human PK study results for NTI164 -
Aussie researchers and ASX biotechs driving paediatric drug breakthroughs
View More: Aussie researchers and ASX biotechs driving paediatric drug breakthroughs -
Neurotech’s NTI164 shows excellent tolerability in key preclinical toxicology studies
View More: Neurotech’s NTI164 shows excellent tolerability in key preclinical toxicology studies -
Neurotech says NTI164 shows positive tolerability in key preclinical toxicology studies
View More: Neurotech says NTI164 shows positive tolerability in key preclinical toxicology studies -
Chelsea Luker: What it’s like having autism and ADHD
View More: Chelsea Luker: What it’s like having autism and ADHD